Global Drugs for Malaria Market Research Report 2021

Global Drugs for Malaria Market Research Report 2021

Table of Contents
1 Drugs for Malaria Market Overview
1.1 Product Overview and Scope of Drugs for Malaria
1.2 Drugs for Malaria Segment by Type
1.2.1 Global Drugs for Malaria Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Aryl Aminoalcohol Compounds
1.2.3 Antifolate Compounds
1.2.4 Artemisinin Compounds
1.3 Drugs for Malaria Segment by Application
1.3.1 Drugs for Malaria Sales Comparison by Application: (2021-2027)
1.3.2 Prevention
1.3.3 Treatment
1.3.4 Others
1.4 Global Drugs for Malaria Market Size Estimates and Forecasts
1.4.1 Global Drugs for Malaria Revenue 2016-2027
1.4.2 Global Drugs for Malaria Sales 2016-2027
1.4.3 Drugs for Malaria Market Size by Region: 2016 Versus 2021 Versus 2027
2 Drugs for Malaria Market Competition by Manufacturers
2.1 Global Drugs for Malaria Sales Market Share by Manufacturers (2016-2021)
2.2 Global Drugs for Malaria Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Drugs for Malaria Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Drugs for Malaria Manufacturing Sites, Area Served, Product Type
2.5 Drugs for Malaria Market Competitive Situation and Trends
2.5.1 Drugs for Malaria Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Drugs for Malaria Players Market Share by Revenue
2.5.3 Global Drugs for Malaria Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Drugs for Malaria Retrospective Market Scenario by Region
3.1 Global Drugs for Malaria Retrospective Market Scenario in Revenue by Region: 2016-2021
3.2 Global Drugs for Malaria Retrospective Market Scenario in Sales by Region: 2016-2021
3.3 North America Drugs for Malaria Market Facts & Figures by Country
3.3.1 North America Drugs for Malaria Sales by Country
3.3.2 North America Drugs for Malaria Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Drugs for Malaria Market Facts & Figures by Country
3.4.1 Europe Drugs for Malaria Sales by Country
3.4.2 Europe Drugs for Malaria Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Drugs for Malaria Market Facts & Figures by Region
3.5.1 Asia Pacific Drugs for Malaria Sales by Region
3.5.2 Asia Pacific Drugs for Malaria Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Drugs for Malaria Market Facts & Figures by Country
3.6.1 Latin America Drugs for Malaria Sales by Country
3.6.2 Latin America Drugs for Malaria Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Drugs for Malaria Market Facts & Figures by Country
3.7.1 Middle East and Africa Drugs for Malaria Sales by Country
3.7.2 Middle East and Africa Drugs for Malaria Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Drugs for Malaria Historic Market Analysis by Type
4.1 Global Drugs for Malaria Sales Market Share by Type (2016-2021)
4.2 Global Drugs for Malaria Revenue Market Share by Type (2016-2021)
4.3 Global Drugs for Malaria Price by Type (2016-2021)
5 Global Drugs for Malaria Historic Market Analysis by Application
5.1 Global Drugs for Malaria Sales Market Share by Application (2016-2021)
5.2 Global Drugs for Malaria Revenue Market Share by Application (2016-2021)
5.3 Global Drugs for Malaria Price by Application (2016-2021)
6 Key Companies Profiled
6.1 Cipla
6.1.1 Cipla Corporation Information
6.1.2 Cipla Description and Business Overview
6.1.3 Cipla Drugs for Malaria Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Cipla Product Portfolio
6.1.5 Cipla Recent Developments/Updates
6.2 Guilin Pharmaceutical
6.2.1 Guilin Pharmaceutical Corporation Information
6.2.2 Guilin Pharmaceutical Description and Business Overview
6.2.3 Guilin Pharmaceutical Drugs for Malaria Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Guilin Pharmaceutical Product Portfolio
6.2.5 Guilin Pharmaceutical Recent Developments/Updates
6.3 IPCA Laboratories
6.3.1 IPCA Laboratories Corporation Information
6.3.2 IPCA Laboratories Description and Business Overview
6.3.3 IPCA Laboratories Drugs for Malaria Sales, Revenue and Gross Margin (2016-2021)
6.3.4 IPCA Laboratories Product Portfolio
6.3.5 IPCA Laboratories Recent Developments/Updates
6.4 GlaxoSmithKline
6.4.1 GlaxoSmithKline Corporation Information
6.4.2 GlaxoSmithKline Description and Business Overview
6.4.3 GlaxoSmithKline Drugs for Malaria Sales, Revenue and Gross Margin (2016-2021)
6.4.4 GlaxoSmithKline Product Portfolio
6.4.5 GlaxoSmithKline Recent Developments/Updates
6.5 Mylan Labs
6.5.1 Mylan Labs Corporation Information
6.5.2 Mylan Labs Description and Business Overview
6.5.3 Mylan Labs Drugs for Malaria Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Mylan Labs Product Portfolio
6.5.5 Mylan Labs Recent Developments/Updates
6.6 Roche
6.6.1 Roche Corporation Information
6.6.2 Roche Description and Business Overview
6.6.3 Roche Drugs for Malaria Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Roche Product Portfolio
6.6.5 Roche Recent Developments/Updates
6.7 Novartis
6.6.1 Novartis Corporation Information
6.6.2 Novartis Description and Business Overview
6.6.3 Novartis Drugs for Malaria Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Novartis Product Portfolio
6.7.5 Novartis Recent Developments/Updates
6.8 Sanofi Aventis
6.8.1 Sanofi Aventis Corporation Information
6.8.2 Sanofi Aventis Description and Business Overview
6.8.3 Sanofi Aventis Drugs for Malaria Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Sanofi Aventis Product Portfolio
6.8.5 Sanofi Aventis Recent Developments/Updates
6.9 Ajanta Pharma
6.9.1 Ajanta Pharma Corporation Information
6.9.2 Ajanta Pharma Description and Business Overview
6.9.3 Ajanta Pharma Drugs for Malaria Sales, Revenue and Gross Margin (2016-2021)
6.9.4 Ajanta Pharma Product Portfolio
6.9.5 Ajanta Pharma Recent Developments/Updates
7 Drugs for Malaria Manufacturing Cost Analysis
7.1 Drugs for Malaria Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Drugs for Malaria
7.4 Drugs for Malaria Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Drugs for Malaria Distributors List
8.3 Drugs for Malaria Customers
9 Drugs for Malaria Market Dynamics
9.1 Drugs for Malaria Industry Trends
9.2 Drugs for Malaria Growth Drivers
9.3 Drugs for Malaria Market Challenges
9.4 Drugs for Malaria Market Restraints
10 Global Market Forecast
10.1 Drugs for Malaria Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Drugs for Malaria by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Drugs for Malaria by Type (2022-2027)
10.2 Drugs for Malaria Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Drugs for Malaria by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Drugs for Malaria by Application (2022-2027)
10.3 Drugs for Malaria Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Drugs for Malaria by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Drugs for Malaria by Region (2022-2027)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Drugs for Malaria Sales (K Units) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Drugs for Malaria Sales (K Units) Comparison by Application (2021-2027)
Table 3. Global Drugs for Malaria Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Drugs for Malaria Covered in This Study
Table 5. Global Drugs for Malaria Sales (K Units) of Key Manufacturers (2016-2021)
Table 6. Global Drugs for Malaria Sales Share by Manufacturers (2016-2021)
Table 7. Global Drugs for Malaria Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Drugs for Malaria Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Drugs for Malaria Average Price (USD/Unit) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Drugs for Malaria Manufacturing Sites and Area Served
Table 11. Manufacturers Drugs for Malaria Product Type
Table 12. Global Drugs for Malaria Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Drugs for Malaria by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Drugs for Malaria as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Drugs for Malaria Sales by Region (2016-2021) & (K Units)
Table 16. Global Drugs for Malaria Sales Market Share by Region (2016-2021)
Table 17. Global Drugs for Malaria Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Drugs for Malaria Sales by Country (2016-2021) & (K Units)
Table 19. North America Drugs for Malaria Sales Market Share by Country (2016-2021)
Table 20. North America Drugs for Malaria Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Drugs for Malaria Revenue Market Share by Country (2016-2021)
Table 22. Europe Drugs for Malaria Sales by Country (2016-2021) & (K Units)
Table 23. Europe Drugs for Malaria Sales Market Share by Country (2016-2021)
Table 24. Europe Drugs for Malaria Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Drugs for Malaria Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Drugs for Malaria Sales by Region (2016-2021) & (K Units)
Table 27. Asia Pacific Drugs for Malaria Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Drugs for Malaria Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Drugs for Malaria Revenue Market Share by Region (2016-2021)
Table 30. Latin America Drugs for Malaria Sales by Country (2016-2021) & (K Units)
Table 31. Latin America Drugs for Malaria Sales Market Share by Country (2016-2021)
Table 32. Latin America Drugs for Malaria Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Drugs for Malaria Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Drugs for Malaria Sales by Country (2016-2021) & (K Units)
Table 35. Middle East and Africa Drugs for Malaria Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Drugs for Malaria Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Drugs for Malaria Revenue Market Share by Country (2016-2021)
Table 38. Global Drugs for Malaria Sales (K Units) by Type (2016-2021)
Table 39. Global Drugs for Malaria Sales Market Share by Type (2016-2021)
Table 40. Global Drugs for Malaria Revenue (Million US$) by Type (2016-2021)
Table 41. Global Drugs for Malaria Revenue Share by Type (2016-2021)
Table 42. Global Drugs for Malaria Price (USD/Unit) by Type (2016-2021)
Table 43. Global Drugs for Malaria Sales (K Units) by Application (2016-2021)
Table 44. Global Drugs for Malaria Sales Market Share by Application (2016-2021)
Table 45. Global Drugs for Malaria Revenue (Million US$) by Application (2016-2021)
Table 46. Global Drugs for Malaria Revenue Share by Application (2016-2021)
Table 47. Global Drugs for Malaria Price (USD/Unit) by Application (2016-2021)
Table 48. Cipla Corporation Information
Table 49. Cipla Description and Business Overview
Table 50. Cipla Drugs for Malaria Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 51. Cipla Drugs for Malaria Product
Table 52. Cipla Recent Developments/Updates
Table 53. Guilin Pharmaceutical Corporation Information
Table 54. Guilin Pharmaceutical Description and Business Overview
Table 55. Guilin Pharmaceutical Drugs for Malaria Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 56. Guilin Pharmaceutical Drugs for Malaria Product
Table 57. Guilin Pharmaceutical Recent Developments/Updates
Table 58. IPCA Laboratories Corporation Information
Table 59. IPCA Laboratories Description and Business Overview
Table 60. IPCA Laboratories Drugs for Malaria Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 61. IPCA Laboratories Drugs for Malaria Product
Table 62. IPCA Laboratories Recent Developments/Updates
Table 63. GlaxoSmithKline Corporation Information
Table 64. GlaxoSmithKline Description and Business Overview
Table 65. GlaxoSmithKline Drugs for Malaria Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 66. GlaxoSmithKline Drugs for Malaria Product
Table 67. GlaxoSmithKline Recent Developments/Updates
Table 68. Mylan Labs Corporation Information
Table 69. Mylan Labs Description and Business Overview
Table 70. Mylan Labs Drugs for Malaria Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 71. Mylan Labs Drugs for Malaria Product
Table 72. Mylan Labs Recent Developments/Updates
Table 73. Roche Corporation Information
Table 74. Roche Description and Business Overview
Table 75. Roche Drugs for Malaria Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 76. Roche Drugs for Malaria Product
Table 77. Roche Recent Developments/Updates
Table 78. Novartis Corporation Information
Table 79. Novartis Description and Business Overview
Table 80. Novartis Drugs for Malaria Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 81. Novartis Drugs for Malaria Product
Table 82. Novartis Recent Developments/Updates
Table 83. Sanofi Aventis Corporation Information
Table 84. Sanofi Aventis Description and Business Overview
Table 85. Sanofi Aventis Drugs for Malaria Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 86. Sanofi Aventis Drugs for Malaria Product
Table 87. Sanofi Aventis Recent Developments/Updates
Table 88. Ajanta Pharma Corporation Information
Table 89. Ajanta Pharma Description and Business Overview
Table 90. Ajanta Pharma Drugs for Malaria Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 91. Ajanta Pharma Drugs for Malaria Product
Table 92. Ajanta Pharma Recent Developments/Updates
Table 93. Production Base and Market Concentration Rate of Raw Material
Table 94. Key Suppliers of Raw Materials
Table 95. Drugs for Malaria Distributors List
Table 96. Drugs for Malaria Customers List
Table 97. Drugs for Malaria Market Trends
Table 98. Drugs for Malaria Growth Drivers
Table 99. Drugs for Malaria Market Restraints
Table 100. Global Drugs for Malaria Sales Forecast by Type (2022-2027) & (K Units)
Table 101. Global Drugs for Malaria Sales Market Share Forecast by Type (2022-2027)
Table 102. Global Drugs for Malaria Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 103. Global Drugs for Malaria Revenue Market Share Forecast by Type (2022-2027)
Table 104. Global Drugs for Malaria Sales Forecast by Application (2022-2027) & (K Units)
Table 105. Global Drugs for Malaria Sales Market Share Forecast by Application (2022-2027)
Table 106. Global Drugs for Malaria Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 107. Global Drugs for Malaria Revenue Market Share Forecast by Application (2022-2027)
Table 108. Global Drugs for Malaria Sales Forecast by Region (2022-2027) & (K Units)
Table 109. Global Drugs for Malaria Sales Market Share Forecast by Region (2022-2027)
Table 110. Global Drugs for Malaria Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 111. Global Drugs for Malaria Revenue Market Share Forecast by Region (2022-2027)
Table 112. Research Programs/Design for This Report
Table 113. Key Data Information from Secondary Sources
Table 114. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Drugs for Malaria
Figure 2. Global Drugs for Malaria Market Share by Type in 2020 & 2027
Figure 3. Aryl Aminoalcohol Compounds Product Picture
Figure 4. Antifolate Compounds Product Picture
Figure 5. Artemisinin Compounds Product Picture
Figure 6. Global Drugs for Malaria Market Share by Application in 2020 & 2027
Figure 7. Prevention
Figure 8. Treatment
Figure 9. Others
Figure 10. Global Drugs for Malaria Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Drugs for Malaria Market Size 2016-2027 (US$ Million)
Figure 12. Global Drugs for Malaria Sales 2016-2027 (K Units)
Figure 13. Global Drugs for Malaria Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 14. Drugs for Malaria Sales Share by Manufacturers in 2020
Figure 15. Global Drugs for Malaria Revenue Share by Manufacturers in 2020
Figure 16. The Global 5 and 10 Largest Drugs for Malaria Players: Market Share by Revenue in 2020
Figure 17. Drugs for Malaria Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 18. Global Drugs for Malaria Sales Market Share by Region (2016-2021)
Figure 19. Global Drugs for Malaria Sales Market Share by Region in 2020
Figure 20. Global Drugs for Malaria Revenue Market Share by Region (2016-2021)
Figure 21. Global Drugs for Malaria Revenue Market Share by Region in 2020
Figure 22. U.S. Drugs for Malaria Revenue Growth Rate (2016-2021) (US$ Million)
Figure 23. Canada Drugs for Malaria Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. Germany Drugs for Malaria Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. France Drugs for Malaria Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. U.K. Drugs for Malaria Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. Italy Drugs for Malaria Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. Russia Drugs for Malaria Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. China Drugs for Malaria Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. Japan Drugs for Malaria Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. South Korea Drugs for Malaria Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. India Drugs for Malaria Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. Australia Drugs for Malaria Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Taiwan Drugs for Malaria Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Indonesia Drugs for Malaria Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Thailand Drugs for Malaria Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Malaysia Drugs for Malaria Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Philippines Drugs for Malaria Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Vietnam Drugs for Malaria Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Mexico Drugs for Malaria Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Brazil Drugs for Malaria Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Argentina Drugs for Malaria Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Turkey Drugs for Malaria Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Saudi Arabia Drugs for Malaria Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. U.A.E Drugs for Malaria Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. Sales Market Share of Drugs for Malaria by Type (2016-2021)
Figure 47. Sales Market Share of Drugs for Malaria by Application (2016-2021)
Figure 48. Sales Market Share of Drugs for Malaria by Application in 2020
Figure 49. Revenue Share of Drugs for Malaria by Application (2016-2021)
Figure 50. Revenue Share of Drugs for Malaria by Application in 2020
Figure 51. Manufacturing Cost Structure of Drugs for Malaria
Figure 52. Manufacturing Process Analysis of Drugs for Malaria
Figure 53. Drugs for Malaria Industrial Chain Analysis
Figure 54. Channels of Distribution
Figure 55. Distributors Profiles
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Dihydroartemisinin Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 88

The global Dihydroartemisinin market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Dihydroartemisinin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Dihydroartemisinin is estimated to increase from $ million in 2023 to reach $ million by 2......

Global Artemisinin Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 114

According to our LPI (LP Information) latest study, the global Artemisinin market size was valued at US$ 61 million in 2023. With growing demand in downstream market, the Artemisinin is forecast to a readjusted size of US$ 227 million by 2030 with a CAGR of 20.7% during review period. The research report highlights the growth potential of the global Artemisinin market. Artemisinin are expected to show stable growth in the future market. However, product differentiation, reducing costs, a......

Global Drugs for Malaria Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 90

According to our LPI (LP Information) latest study, the global Drugs for Malaria market size was valued at US$ million in 2023. With growing demand in downstream market, the Drugs for Malaria is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global Drugs for Malaria market. Drugs for Malaria are expected to show stable growth in the future market. However, product differentiation, reduc......

Dihydroartemisinin - Global Market Insights and Sales Trends 2024

Published: 21-Dec-2023        Price: US 3350 Onwards        Pages: 99

The global Dihydroartemisinin market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Dihydroartemisinin in various end use industries. The expanding demands from the Malaria Treatment, Scientific Research and Others,, are propelling Dihydroartemisinin market. Pharmaceutical Grade, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the......

Global Drugs For Malaria Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 05-Dec-2023        Price: US 3380 Onwards        Pages: 100

Market Overview of Global Drugs For Malaria market: According to our latest research, the global Drugs For Malaria market looks promising in the next 5 years. As of 2022, the global Drugs For Malaria market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. It is Anti-malarial drug. Anti-malarial drugs are the medicines used to prevent and treat malaria. The malaria is the disease caused due to ......

Global Artemisinin Professional Survey Report 2023, Forecast to 2028

Published: 15-Nov-2023        Price: US 3280 Onwards        Pages: 105

Artemisinin and its semisynthetic derivatives are a group of drugs used in the treatment of malaria due to Plasmodium falciparum. It was discovered in 1972 by Tu Youyou, who shared the 2015 Nobel Prize in Physiology or Medicine for her discovery. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clie......

Global Artemisinin Market Research Report 2023, Forecast to 2028

Published: 15-Nov-2023        Price: US 2680 Onwards        Pages: 131

Artemisinin and its semisynthetic derivatives are a group of drugs used in the treatment of malaria due to Plasmodium falciparum. It was discovered in 1972 by Tu Youyou, who shared the 2015 Nobel Prize in Physiology or Medicine for her discovery. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clie......

Global Dihydroartemisinin Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 24-Oct-2023        Price: US 3380 Onwards        Pages: 127

Market Overview of Global Dihydroartemisinin market: According to our latest research, the global Dihydroartemisinin market looks promising in the next 5 years. As of 2022, the global Dihydroartemisinin market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Dihydroartemisini......

Global Artemisinin Market Insights, Forecast to 2029

Published: 20-Sep-2023        Price: US 4900 Onwards        Pages: 108

Artemisinin is a sesquiterpene lactone containing an unusual peroxide bridge which possesses the most rapid action of all current drugs against Plasmodium falciparum malaria. It is isolated from the plant Artemisia annua, sweet wormwood, an herb employed in Chinese traditional medicine. It can now also be produced using genetically engineered yeast. The global Artemisinin market is projected to grow from US$ 75 million in 2023 to US$ 225.3 million by 2029, at a Compound Annual Growth Rate......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs